Literature DB >> 33110470

Pharmacists' perspectives on the value of reason for use information.

Colin Whaley1,2, Ashley Bancsi1,2, Catherine Burns1,2, Kelly Grindrod1,2.   

Abstract

BACKGROUND: The indication for a particular medication, or its reason for use (RFU), is important information for prescribers, pharmacists and patients but is not often communicated in writing from prescribers to pharmacists. Adding RFU to a prescription and a medication label would ensure that pharmacists are confident that they are providing high-quality, accurate patient care. This study aims to describe the perspectives of pharmacists on how receiving RFU from prescribers would affect their practice and how pharmacists putting this information on prescriptions would affect patients.
METHODS: Semi-structured qualitative interviews were conducted with 20 pharmacists in Southwestern Ontario. Thematic analysis was used to analyze the interview transcripts, leading to 4 major themes.
RESULTS: Pharmacists expressed that RFU should be formatted to ensure that it is of clinical utility via the use of written text and noted that either medical or lay (also known as plain) language would be appropriate for use. Pharmacists indicated that patient privacy should be considered when writing RFU on labels and that patient preference with respect to the addition of RFU should dictate its inclusion on a medication label. Pharmacist access to RFU was universally acknowledged to improve patient safety by providing pharmacists with more information to determine whether the given medication was indicated.
CONCLUSIONS: This study provides further information about the impact that having access to RFU would have on pharmacy practice and can be used to advocate for the inclusion of RFU information with prescriptions to improve patient outcomes. Can Pharm J (Ott) 2020;153:xx-xx.
© The Author(s) 2020.

Entities:  

Year:  2020        PMID: 33110470      PMCID: PMC7560559          DOI: 10.1177/1715163520946052

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  12 in total

1.  Reason for Use: An Opportunity to Improve Patient Safety.

Authors:  Reicelis Casares Li; Thana Hussein; Ashley Bancsi; Kelly Grindrod; Catherine Burns
Journal:  Stud Health Technol Inform       Date:  2019

2.  Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study.

Authors:  Terri L Warholak; Michael T Rupp; Sandra Leal; Guntur Kurniawan; Nisha Patel
Journal:  Res Social Adm Pharm       Date:  2013-05-17

3.  Standards for reporting qualitative research: a synthesis of recommendations.

Authors:  Bridget C O'Brien; Ilene B Harris; Thomas J Beckman; Darcy A Reed; David A Cook
Journal:  Acad Med       Date:  2014-09       Impact factor: 6.893

Review 4.  Incorporating medication indications into the prescribing process.

Authors:  Kevin Kron; Sara Myers; Lynn Volk; Aaron Nathan; Pamela Neri; Alejandra Salazar; Mary G Amato; Adam Wright; Sam Karmiy; Sarah McCord; Enrique Seoane-Vazquez; Tewodros Eguale; Rosa Rodriguez-Monguio; David W Bates; Gordon Schiff
Journal:  Am J Health Syst Pharm       Date:  2018-04-19       Impact factor: 2.637

5.  Factors contributing to the identification and prevention of incorrect drug prescribing errors in outpatient setting.

Authors:  Salma Al-Khani; Amani Moharram; Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2013-11-19       Impact factor: 4.330

6.  A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.

Authors:  Michael S Wolf; Terry C Davis; Laura M Curtis; Stacy Cooper Bailey; JoAnn Pearson Knox; Ashley Bergeron; Mercedes Abbet; William H Shrank; Ruth M Parker; Alastair J J Wood
Journal:  J Gen Intern Med       Date:  2016-08-19       Impact factor: 5.128

7.  Older patient, physician and pharmacist perspectives about community pharmacists' roles.

Authors:  Derjung M Tarn; Debora A Paterniti; Neil S Wenger; Bradley R Williams; Betty A Chewning
Journal:  Int J Pharm Pract       Date:  2012-04-11

8.  Randomized trial to improve prescribing safety in ambulatory elderly patients.

Authors:  Marsha A Raebel; Jeanya Charles; Jennifer Dugan; Nikki M Carroll; Eli J Korner; David W Brand; David J Magid
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562

9.  Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems.

Authors:  Pamela M Garabedian; Adam Wright; Isabella Newbury; Lynn A Volk; Alejandra Salazar; Mary G Amato; Aaron W Nathan; Katherine J Forsythe; William L Galanter; Kevin Kron; Sara Myers; Joanna Abraham; Sarah K McCord; Tewodros Eguale; David W Bates; Gordon D Schiff
Journal:  JAMA Netw Open       Date:  2019-03-01

10.  Saturation in qualitative research: exploring its conceptualization and operationalization.

Authors:  Benjamin Saunders; Julius Sim; Tom Kingstone; Shula Baker; Jackie Waterfield; Bernadette Bartlam; Heather Burroughs; Clare Jinks
Journal:  Qual Quant       Date:  2017-09-14
View more
  2 in total

1.  Prescribers' perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.

Authors:  Colin Whaley; Ashley Bancsi; Joanne Man-Wai Ho; Catherine M Burns; Kelly Grindrod
Journal:  BMC Health Serv Res       Date:  2021-01-26       Impact factor: 2.655

2.  Incorporating 'reason for use' into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium.

Authors:  Marijke Peeters; Elias Iturrospe; Dominique Jans; Alexander L N van Nuijs; Hans De Loof
Journal:  BMC Health Serv Res       Date:  2022-09-30       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.